87149001 - KISIMA

Information

• Trademark
• 87149001

• Source

• Serial Number

  87149001

• Registration Number

  5577986

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  August 24, 2016
  8 years ago

• Registration Date

  October 09, 2018
  6 years ago

• Transaction Date

  October 09, 2023
  a year ago

• Status Date

  October 09, 2018
  6 years ago

• Published for Opposition Date

  July 24, 2018
  6 years ago

• Location Date

  October 09, 2018
  6 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  IM, JEAN H

• Attorney Docket Number

  067249-0016

  Attorney Name

  Jennifer Fraser

  Law Office Assigned Location Code

  L10

• Owners

  • AMAL THERAPEUTICS, S.A

Case File Statements

• GS0051: Pharmaceutical, medical and veterinary preparations, namely, proteins, peptides, and modified peptides for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; proteins and derivatives of peptides and proteins as well as protein- and peptide-pools for medical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; macromolecules, namely, peptides, proteins, nucleic acids and derivatives of peptides, proteins, and nucleic acids for medical and pharmaceutical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; diagnostic preparations for medical and veterinary use; biological preparations, namely, proteins, peptides, modified peptides for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; cells for medical purposes; pharmaceutical preparations and compositions, namely, pharmaceutical preparations and compositions for the treatment and prevention of cancer; nucleic acids, in particular recombinant nucleic acids; nucleic acids for medical purposes, namely, for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; nucleic acid sequences for medical purposes, namely, for diagnostic purposes and the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; proteins for medical purposes, namely, for diagnostic purposes and for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; macromolecules and biologically active substances for medical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; kits containing preparations for medical purposes, comprised primarily of pharmaceutical preparations for the treatment and prevention of tumor and cancer diseases, and pharmaceutical preparations namely, proteins, peptides, modified peptides for the treatment and prevention of infectious diseases, and autoimmune diseases
• GS0011: Peptides, proteins, modified peptides and proteins and derivatives of peptides and proteins used in industry and science, in particular peptides, proteins, modified peptides and proteins and derivatives of peptides and proteins for industrial and scientific purposes, all the foregoing being chemical preparations for industrial and scientific use; biochemical products, in the nature of biochemical preparations and substances for analyses in laboratories; diagnostic preparations containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific purposes; peptide substrates for scientific purposes, namely, biochemical peptide substrates for laboratory or research use; proteins for use in science, industry and manufacture; biological preparations, namely, cell cultures, tissue cultures; chemical reagents containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific and research purposes and biochemical reagents containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific and research purposes; nucleic acids, in particular recombinant nucleic acids; nucleic acids for scientific purposes; nucleic acid sequences; biological active peptides for scientific and research purposes; antisera for scientific and industrial purposes; all above other than for medical and veterinary use
• TR0010: The English translation of "KISIMA" in the mark is "WATER WELL".
• GS0441: Medical services; Veterinary services; Hygienic and beauty care for human beings or animals; Agriculture, horticulture and forestry services, namely, pest control for agriculture, horticulture and forestry, farming services in the field of grain; Pharmaceutical services, namely, pharmaceutical advice, pharmaceutical compounding services; Medical information
• GS0421: Scientific and technological services and research and design relating thereto, namely, scientific research, analysis and testing in the field of pharmaceuticals, medicine, biochemistry and biotechnology, and design of biochemical macromolecules, in particular proteins, peptides and nucleic acids, and biochemical preparations for scientific, medical and industrial use; Industrial analysis and research services in the field of pharmaceuticals, medicine, biochemistry and biotechnology; research and development services all relating to science; medical product and pharmaceutical research and development services; biological scientific research and development and clinical scientific research and development services; research and development services all relating to industry in the field of pharmaceuticals, medicine, biochemistry and biotechnology; research and development services all relating to biochemistry and biotechnology; research and development services all relating to products and tools to be used in biotechnical, biochemical, medical and pharmaceutical research; medical and pharmacological research services; medical research; scientific research for medical purposes; laboratory research services in the field of protein, peptide and molecular biology; provision of information and data relating to medical product and scientific research and development; medical and pharmaceutical product development and evaluation; Pharmaceutical, medical, biotechnological and biochemical research and development services for the pharmaceutical industry; Information technology services for the pharmaceutical and healthcare industries, namely, planning, design and management of information technology systems, consulting in the field of information technology, design and development of computer software

Case File Event Statements

• 10/9/2023 - a year ago

  29 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 10/9/2018 - 6 years ago

  28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 7/24/2018 - 6 years ago

  27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/24/2018 - 6 years ago

  26 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/4/2018 - 6 years ago

  25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/20/2018 - 6 years ago

  24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/18/2018 - 6 years ago

  23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/18/2018 - 6 years ago

  22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/11/2018 - 6 years ago

  21 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/11/2018 - 6 years ago

  20 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 12/20/2017 - 7 years ago

  19 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/20/2017 - 7 years ago

  18 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/20/2017 - 7 years ago

  17 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/28/2017 - 7 years ago

  16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/28/2017 - 7 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/26/2017 - 7 years ago

  14 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 6/8/2017 - 7 years ago

  13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 6/8/2017 - 7 years ago

  12 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 6/8/2017 - 7 years ago

  11 - SUSPENSION LETTER WRITTEN Type: CNSL

• 5/16/2017 - 7 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/16/2017 - 7 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/12/2017 - 7 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 4/20/2017 - 7 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/7/2016 - 8 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/7/2016 - 8 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/7/2016 - 8 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/5/2016 - 8 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/29/2016 - 8 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/27/2016 - 8 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP